Does the media favor HIMS or FTRE?

In the previous week, Hims & Hers Health had 2 more articles in the media than Fortrea. MarketBeat recorded 26 mentions for Hims & Hers Health and 24 mentions for Fortrea. Fortrea's average media sentiment score of 0.81 beat Hims & Hers Health's score of 0.22 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 5 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 5 Negative mention(s) 3 Very Negative mention(s) Neutral Fortrea 8 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, BLLN or FTRE?

Billiontoone has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 20.62 $7.45M $0.55 248.74 Fortrea $2.72B 0.65 -$986.20M -$0.91 N/A

Does the media prefer BLLN or FTRE?

In the previous week, Fortrea had 19 more articles in the media than Billiontoone. MarketBeat recorded 24 mentions for Fortrea and 5 mentions for Billiontoone. Fortrea's average media sentiment score of 0.81 beat Billiontoone's score of 0.41 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 8 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is SHC or FTRE more profitable?

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -3.18%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 9.91% 39.73% 7.05% Fortrea -3.18% 10.72% 2.17%

Does the media prefer SHC or FTRE?

In the previous week, Fortrea had 14 more articles in the media than Sotera Health. MarketBeat recorded 24 mentions for Fortrea and 10 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.35 beat Fortrea's score of 0.81 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 8 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, RDNT or FTRE?

RadNet has higher earnings, but lower revenue than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.56 -$18.65M -$0.18 N/A Fortrea $2.72B 0.65 -$986.20M -$0.91 N/A

Is RDNT or FTRE more profitable?

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -3.18%. Fortrea's return on equity of 10.72% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Fortrea -3.18% 10.72% 2.17%

Does the media prefer RDNT or FTRE?

In the previous week, Fortrea had 19 more articles in the media than RadNet. MarketBeat recorded 24 mentions for Fortrea and 5 mentions for RadNet. Fortrea's average media sentiment score of 0.81 beat RadNet's score of 0.42 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 8 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, FTRE or VCYT?

Veracyte has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fortrea $2.72B 0.65 -$986.20M -$0.91 N/A Veracyte $561.90M 6.52 $66.35M $1.41 32.55

Is FTRE or VCYT more profitable?

Veracyte has a net margin of 20.37% compared to Fortrea's net margin of -3.18%. Fortrea's return on equity of 10.72% beat Veracyte's return on equity. Company Net Margins Return on Equity Return on Assets Fortrea -3.18% 10.72% 2.17% Veracyte 20.37% 9.26% 8.61%

Does the media favor FTRE or VCYT?

In the previous week, Fortrea had 5 more articles in the media than Veracyte. MarketBeat recorded 24 mentions for Fortrea and 19 mentions for Veracyte. Fortrea's average media sentiment score of 0.81 beat Veracyte's score of 0.63 indicating that Fortrea is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 8 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 7 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Fortrea (FTRE) Competitors

$18.49 -0.68 (-3.54%)

As of 11:40 AM Eastern

Compare

FTRE vs. HIMS, BLLN, SHC, RDNT, and VCYT

Should you buy Fortrea stock or one of its competitors? MarketBeat compares Fortrea with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortrea include Hims & Hers Health (HIMS), Billiontoone (BLLN), Sotera Health (SHC), RadNet (RDNT), and Veracyte (VCYT).

How does Fortrea compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Fortrea (NASDAQ:FTRE) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Hims & Hers Health has a net margin of -0.56% compared to Fortrea's net margin of -3.18%. Fortrea's return on equity of 10.72% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Fortrea	-3.18%	10.72%	2.17%

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 0.7% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Hims & Hers Health presently has a consensus target price of $31.43, suggesting a potential upside of 2.87%. Fortrea has a consensus target price of $19.95, suggesting a potential upside of 7.89%. Given Fortrea's stronger consensus rating and higher possible upside, analysts plainly believe Fortrea is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.50

Hims & Hers Health has a beta of 2.35, indicating that its share price is 135% more volatile than the broader market. Comparatively, Fortrea has a beta of 1.99, indicating that its share price is 99% more volatile than the broader market.

Hims & Hers Health has higher earnings, but lower revenue than Fortrea. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.37B	2.98	$128.37M	-$0.09	N/A
Fortrea	$2.72B	0.65	-$986.20M	-$0.91	N/A

In the previous week, Hims & Hers Health had 2 more articles in the media than Fortrea. MarketBeat recorded 26 mentions for Hims & Hers Health and 24 mentions for Fortrea. Fortrea's average media sentiment score of 0.81 beat Hims & Hers Health's score of 0.22 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	5 Negative mention(s)	3 Very Negative mention(s)	Neutral
Fortrea	8 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Fortrea beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks.

How does Fortrea compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Fortrea (NASDAQ:FTRE) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Billiontoone currently has a consensus price target of $126.00, indicating a potential downside of 7.90%. Fortrea has a consensus price target of $19.95, indicating a potential upside of 7.89%. Given Fortrea's higher probable upside, analysts plainly believe Fortrea is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.50

Billiontoone has a net margin of 0.00% compared to Fortrea's net margin of -3.18%. Fortrea's return on equity of 10.72% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Fortrea	-3.18%	10.72%	2.17%

Billiontoone has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	20.62	$7.45M	$0.55	248.74
Fortrea	$2.72B	0.65	-$986.20M	-$0.91	N/A

In the previous week, Fortrea had 19 more articles in the media than Billiontoone. MarketBeat recorded 24 mentions for Fortrea and 5 mentions for Billiontoone. Fortrea's average media sentiment score of 0.81 beat Billiontoone's score of 0.41 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fortrea	8 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Fortrea beats Billiontoone on 7 of the 13 factors compared between the two stocks.

How does Fortrea compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Fortrea (NASDAQ:FTRE) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -3.18%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Fortrea	-3.18%	10.72%	2.17%

Sotera Health currently has a consensus price target of $20.25, suggesting a potential upside of 12.28%. Fortrea has a consensus price target of $19.95, suggesting a potential upside of 7.89%. Given Sotera Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Sotera Health is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.50

Sotera Health has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.19B	4.32	$77.94M	$0.41	43.99
Fortrea	$2.72B	0.65	-$986.20M	-$0.91	N/A

In the previous week, Fortrea had 14 more articles in the media than Sotera Health. MarketBeat recorded 24 mentions for Fortrea and 10 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.35 beat Fortrea's score of 0.81 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	7 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fortrea	8 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 0.7% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sotera Health has a beta of 1.76, meaning that its stock price is 76% more volatile than the broader market. Comparatively, Fortrea has a beta of 1.99, meaning that its stock price is 99% more volatile than the broader market.

Summary

Sotera Health beats Fortrea on 13 of the 17 factors compared between the two stocks.

How does Fortrea compare to RadNet?

RadNet (NASDAQ:RDNT) and Fortrea (NASDAQ:FTRE) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

77.9% of RadNet shares are held by institutional investors. 5.1% of RadNet shares are held by company insiders. Comparatively, 0.7% of Fortrea shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

RadNet presently has a consensus target price of $87.43, indicating a potential upside of 31.45%. Fortrea has a consensus target price of $19.95, indicating a potential upside of 7.89%. Given RadNet's stronger consensus rating and higher probable upside, research analysts plainly believe RadNet is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.50

RadNet has higher earnings, but lower revenue than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.56	-$18.65M	-$0.18	N/A
Fortrea	$2.72B	0.65	-$986.20M	-$0.91	N/A

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -3.18%. Fortrea's return on equity of 10.72% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Fortrea	-3.18%	10.72%	2.17%

RadNet has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market. Comparatively, Fortrea has a beta of 1.99, indicating that its stock price is 99% more volatile than the broader market.

In the previous week, Fortrea had 19 more articles in the media than RadNet. MarketBeat recorded 24 mentions for Fortrea and 5 mentions for RadNet. Fortrea's average media sentiment score of 0.81 beat RadNet's score of 0.42 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fortrea	8 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

RadNet beats Fortrea on 10 of the 17 factors compared between the two stocks.

How does Fortrea compare to Veracyte?

Fortrea (NASDAQ:FTRE) and Veracyte (NASDAQ:VCYT) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

Fortrea has a beta of 1.99, suggesting that its stock price is 99% more volatile than the broader market. Comparatively, Veracyte has a beta of 1.93, suggesting that its stock price is 93% more volatile than the broader market.

Veracyte has a net margin of 20.37% compared to Fortrea's net margin of -3.18%. Fortrea's return on equity of 10.72% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-3.18%	10.72%	2.17%
Veracyte	20.37%	9.26%	8.61%

Veracyte has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.65	-$986.20M	-$0.91	N/A
Veracyte	$561.90M	6.52	$66.35M	$1.41	32.55

In the previous week, Fortrea had 5 more articles in the media than Veracyte. MarketBeat recorded 24 mentions for Fortrea and 19 mentions for Veracyte. Fortrea's average media sentiment score of 0.81 beat Veracyte's score of 0.63 indicating that Fortrea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	8 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veracyte	7 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Fortrea currently has a consensus target price of $19.95, suggesting a potential upside of 7.89%. Veracyte has a consensus target price of $56.13, suggesting a potential upside of 22.30%. Given Veracyte's stronger consensus rating and higher probable upside, analysts clearly believe Veracyte is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.50
Veracyte	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.60

Summary

Veracyte beats Fortrea on 8 of the 13 factors compared between the two stocks.

Get Fortrea News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTRE vs. The Competition

Export

Metric	Fortrea	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.75B	$9.10B	$6.79B	$12.63B
Dividend Yield	N/A	1.47%	2.59%	10.03%
P/E Ratio	-20.26	59.36	282.14	25.05
Price / Sales	0.65	276.15	573.43	80.07
Price / Cash	1.93	25.63	28.60	46.71
Price / Book	3.03	5.12	11.09	6.19
Net Income	-$986.20M	$57.47B	$3.49B	$347.61M
7 Day Performance	-3.69%	1.21%	0.42%	0.74%
1 Month Performance	7.01%	-3.14%	-4.33%	-3.72%
1 Year Performance	238.66%	16.11%	63.09%	20.27%

Fortrea Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTRE Fortrea	2.4056 of 5 stars	$18.49 -3.5%	$19.95 +7.9%	+251.1%	$1.75B	$2.72B	N/A	14,300	Earnings Report Analyst Forecast
HIMS Hims & Hers Health	2.4877 of 5 stars	$30.23 +7.6%	$31.43 +4.0%	-55.6%	$7.00B	$2.37B	N/A	2,442	Upcoming Earnings Gap Up
BLLN Billiontoone	2.6308 of 5 stars	$127.98 +1.5%	$126.00 -1.5%	N/A	$5.80B	$305.11M	232.69	620
SHC Sotera Health	3.4653 of 5 stars	$17.24 -0.6%	$20.25 +17.5%	+60.2%	$4.92B	$1.19B	42.05	3,000	Positive News Upcoming Earnings
RDNT RadNet	3.3774 of 5 stars	$61.51 -0.1%	$87.43 +42.1%	+16.6%	$4.84B	$2.04B	N/A	11,264	Positive News Upcoming Earnings Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTRE) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fortrea (FTRE) Competitors

FTRE vs. HIMS, BLLN, SHC, RDNT, and VCYT

How does Fortrea compare to Hims & Hers Health?

Summary

How does Fortrea compare to Billiontoone?

Summary

How does Fortrea compare to Sotera Health?

Summary

How does Fortrea compare to RadNet?

Summary

How does Fortrea compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fortrea (FTRE) Competitors

FTRE vs. HIMS, BLLN, SHC, RDNT, and VCYT

How does Fortrea compare to Hims & Hers Health?

Is HIMS or FTRE more profitable?

Do institutionals & insiders have more ownership in HIMS or FTRE?

Do analysts rate HIMS or FTRE?

Which has more volatility and risk, HIMS or FTRE?

Which has stronger earnings & valuation, HIMS or FTRE?

Does the media favor HIMS or FTRE?

Summary

How does Fortrea compare to Billiontoone?

Do analysts prefer BLLN or FTRE?

Is BLLN or FTRE more profitable?

Which has stronger valuation and earnings, BLLN or FTRE?

Does the media prefer BLLN or FTRE?

Summary

How does Fortrea compare to Sotera Health?

Is SHC or FTRE more profitable?

Do analysts recommend SHC or FTRE?

Which has better earnings & valuation, SHC or FTRE?

Does the media prefer SHC or FTRE?

Do insiders & institutionals hold more shares of SHC or FTRE?

Which has more volatility and risk, SHC or FTRE?

Summary

How does Fortrea compare to RadNet?

Do insiders & institutionals believe in RDNT or FTRE?

Do analysts rate RDNT or FTRE?

Which has preferable valuation and earnings, RDNT or FTRE?

Is RDNT or FTRE more profitable?

Which has more volatility & risk, RDNT or FTRE?

Does the media prefer RDNT or FTRE?

Summary

How does Fortrea compare to Veracyte?

Which has more risk and volatility, FTRE or VCYT?

Is FTRE or VCYT more profitable?

Which has preferable earnings and valuation, FTRE or VCYT?

Does the media favor FTRE or VCYT?

Do analysts rate FTRE or VCYT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools